ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.65
-0.26%
US Tech 100
19,168.00
0.52%
S&P 500
5,431.60
-0.04%
US Dollar vs CAD
1.37515
0.00%
Bitcoin
66,466.51
0.41%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Rain Oncology Inc (RAIN)

  7. Rain Oncology Inc (RAIN) News

RAIN

Rain Oncology (RAIN)

Rain Oncology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RAIN
DateTimeSourceHeadlineSymbolCompany
02/05/20245:41AMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:RAINRain Oncology Inc
01/30/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RAINRain Oncology Inc
01/26/20243:58PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RAINRain Oncology Inc
01/26/20243:56PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RAINRain Oncology Inc
01/26/20243:55PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RAINRain Oncology Inc
01/26/20243:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAINRain Oncology Inc
01/26/20243:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAINRain Oncology Inc
01/26/20243:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAINRain Oncology Inc
01/26/20243:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAINRain Oncology Inc
01/26/20243:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAINRain Oncology Inc
01/26/20243:32PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:RAINRain Oncology Inc
01/26/20248:26AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAINRain Oncology Inc
01/26/20248:19AMEdgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:RAINRain Oncology Inc
01/26/20248:13AMEdgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:RAINRain Oncology Inc
01/22/20243:15PMEdgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:RAINRain Oncology Inc
01/19/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAINRain Oncology Inc
01/16/20244:22PMEdgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:RAINRain Oncology Inc
01/16/20244:18PMEdgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:RAINRain Oncology Inc
01/03/20241:57PMPR Newswire (US)Kuehn Law Encourages EGLE, ICVX, RAIN, and AYX Investors to Contact Law FirmNASDAQ:RAINRain Oncology Inc
12/28/20237:48PMEdgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:RAINRain Oncology Inc
12/27/20238:27AMEdgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:RAINRain Oncology Inc
12/27/20238:20AMEdgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:RAINRain Oncology Inc
12/14/20235:06AMEdgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:RAINRain Oncology Inc
12/14/20235:06AMEdgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:RAINRain Oncology Inc
12/14/20235:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAINRain Oncology Inc
11/09/20233:05PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RAINRain Oncology Inc
11/09/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAINRain Oncology Inc
09/12/20234:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)NASDAQ:RAINRain Oncology Inc
09/06/20234:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)NASDAQ:RAINRain Oncology Inc
08/29/20234:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)NASDAQ:RAINRain Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:RAIN

Your Recent History

USOTC
CNNA
Cann American (CE)
USOTC
AABB
Asia Broadband (PK)
USOTC
ERHE
ERHC Energy (CE)
USOTC
HHSE
Hannover House (PK)
USOTC
CIVX
CTR Investments and Cons... (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
VXIT
Virexit Technologies (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
RNVA
Rennova Health (PK)
NASDAQ
COOP
Mr Cooper
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
NASDAQ
DJT
Trump Media and Technology
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
BLEG
Branded Legacy (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved